Nanotechnology, Nanomedicine, and AI: Toward the Dream of Global Health Care Equivalency

“Progress in medicine, global access to information and a global age pyramid that is already turning upside-down will increase the demand for good health care. This in turn will increase life expectancy and drive innovation. This re-enforcing circle will change societies’ views on health care. Whereas today it is seen as a cost that needs to be controlled — which slows down progress — it might become the global driving force of innovation and humanity, replacing other areas of public investment focus.”
Harald Stock, President & CEO, ArjoHuntleigh
Introduction
We are very fortunate indeed to be living at a time where the speed of advances in medical technologies is such that we can expect to live increasingly healthier and longer lives; far beyond what would ever have been imagined as possible only a century ago. However, in contrast to our natural inalienable human rights to life, liberty, and the pursuit of happiness, our equally important right to good health (and by extension good health care), which is critical for all of us, is unfortunately either in disarray, dysfunctional, or completely neglected on a global scale.
The State of Health Care Today
A news item released on December 2017, by the World Health Organization (WHO) entitled: “World Bank and WHO: Half the world lacks access to essential health services, 100 million still pushed into extreme poverty because of health expenses”, reported that “800 million people spend at least 10 percent of their household budgets on health expenses for themselves, a sick child or other family member. For almost 100 million people these expenses are high enough to push them into extreme poverty, forcing them to survive on just $1.90 or less a day.” A 2017 report authored by Dr. Margaret Chan (Director-General, WHO) stated that “Nearly 2 billion people have no access to basic medicines, causing a cascade of preventable misery and suffering.” The current state of affairs in the developed world for those who are fortunate enough to have access to medical care, in some cases includes the burden of $1000 per dose, and from $100,000 to $1.21 million per year in individual drug expenditures alone.
What is Global Health Care Equivalency (GHCE)?
Looking ahead over the next 10-30 years, with the rapid emergence of, and synergies between, the disciplines of nanotechnology, nanomedicine, and AI, we can envisage a future world where any individual on the planet has access to the same advanced and cost effective nanomedical diagnostic and therapeutic technologies, no matter how wealthy or impoverished they are, no matter where they happen to reside, or under what conditions they live. Progress toward this goal will be incremental, with each successive wave of nanomedical technologies being more advanced than the previous wave. The tipping point will arrive with the emergence of Molecular Manufacturing (MM), http://ieet.org/index.php/IEET/more/boehm20160115, which will make possible the cost effective fabrication of the classes of advanced autonomous nanomedical devices that Boehm describes in his first book: Nanomedical Device and Systems Design: Challenges, Possibilities, Visions. A situation may then well arise where the entire human population will finally come to realize the inalienable human right of optimal health for life through the establishment of a worldwide health care system under the moniker: “Global Health Care Equivalency” (GHCE). The details and vision for GHCE will be articulated in an upcoming book: Nanotechnology, Nanomedicine, and AI: Toward the Dream of Global Health Care Equivalency that is currently being generated by the originator of this concept (Frank Boehm – CEO of NanoApps Medical Incorporated) in collaboration with numerous thought leading authors.
Perceived Benefits of GHCE
The attainment of GHCE might serve to significantly reduce the perception of individuals in the developing world of being marginalized, at least in terms of health care, which may ultimately translate to conflict reduction. In the developed world, GHCE would serve to dramatically reduce health care expenditures across the board. Progress toward this goal will be incremental, with each successive wave of nanomedical technologies being more advanced than the previous wave. The tipping point will arrive with the emergence of Molecular Manufacturing (MM), http://ieet.org/index.php/IEET/more/boehm20160115, which will make possible the cost effective fabrication of the types of advanced autonomous nanomedical devices that Boehm describes in his first book: Nanomedical Device and Systems Design: Challenges, Possibilities, Visions.
It is worth noting here that all nations on a global scale stand to benefit immensely when their citizens are healthy, as they would save hundreds of millions, if not billions of dollars in health-related expenditures, not to mention lost work hours and overall productivity, due to illness and its associated incapacities.
The core essence of GHCE is aptly conveyed in the thought below:
“In a world facing considerable uncertainty, international health development is a unifying – and uplifting – force for the good of humanity.”
Dr Chan, WHO Director-General
What is Molecular Manufacturing (MM)
The first mention of the possibility of MM emerged through the words of Dr. Richard Feynman in 1959, via his famous talk, “Plenty of Room at the Bottom”, where he spoke of the possibility of the controlled manipulation of matter at the atomic level. Dr. Eric Drexler described the remarkable capabilities that he envisioned for a conceptual molecular assembler in his 1986 book, Engines of Creation. In 2003, Chris Phoenix generated a paper that articulated the Design of a Primitive Nanofactory. Dr. Robert Freitas Jr. et al., have extensively investigated Diamond MechanoSynthesis and personalized Nanofactories from 2002 to the present.
Once MM is developed, it will have the capacity to fabricate just about any consumer item or food, as well as advanced autonomous nanomedical robots from elemental atoms and molecules, guided by AI-driven specifications. By virtue of these fundamental feed stocks, it will likely become very cost effective to fabricate (physician prescribed) nanomedical devices to address virtually any condition that ails us, in one’s own home, via Factory@Home (F@H) units, which might be manifest as countertop microwave-sized appliances that are extensively distributed worldwide. Concurrently, home based atomic and molecular “disassembly” units would be able to completely recycle, sort, and repackage practically any type of material according to its specific atomic and molecular species, which could again be used to supply the F@H units for fabrication.
Awaking the Dream
Although the attainment of GHCE would indeed be a truly extraordinary achievement, we must keenly recognize that in reality, such a massive undertaking on a global scale will require intense and sustained high spirited collaboration between like minded individuals who have widely varied backgrounds within diverse areas of expertise. Highly specialized laboratories, dynamic administrative institutions, regulatory bodies, and government agencies worldwide will also be vital prerequisites for its realization, as will significant resources and time. We are all amazing individuals, each with our own unique talents and expertise that might contribute and be applied to this noble enterprise. Our working together might culminate in a positive critical mass on a global scale toward the actual realization of GHCE, which would ultimately be of benefit for each and every one of us, as we are finally “all” supported in our natural human right of optimal health for life.
News
Tricking the novel coronavirus with a fake ‘handshake’
Scientists have developed protein fragments—called peptides—that fit snugly into a groove on the SARS-CoV-2 Spike protein that it would normally use to access a host cell. These peptides effectively trick the virus into "shaking hands" with a replica rather than with [...]
Researchers reveal genetic predisposition to severe COVID-19
HSE University researchers have become the first in the world to discover genetic predisposition to severe COVID-19. The results of the study were published in the journal Frontiers in Immunology. T-cell immunity is one of [...]
What Pseudoviruses Bring to the Study of SARS-CoV-2
When SARS-CoV-2 first began spreading across the globe, not every lab was equipped to study it directly. The virus behind the current pandemic is highly pathogenic and transmissible, leading the US Centers for Disease [...]
Covid-19: Future targets for treatments rapidly identified with new computer simulations
esearchers have detailed a mechanism in the distinctive corona of Covid-19 that could help scientists to rapidly find new treatments for the virus, and quickly test whether existing treatments are likely to work with [...]
Almost Half of Coronavirus Sufferers Report Depression
Almost half of people testing positive for coronavirus have reported symptoms of depression, according to a new study published in the International Journal of Environmental Research and Public Health. Researchers from Bangladesh, the United States [...]
Six previously FDA-approved drugs appear promising against SARS-CoV-2 in laboratory testing
A team of investigators from the Republic of China has discovered that 6 drugs previously approved by the US Food and Drug Administration (FDA) for other indications could be repurposed to treat or prevent [...]
Graphene could one day be used to make quick, reliable tests for viruses like SARS-CoV-2
Graphene is a layer of carbon only one atom thick. Since it was first isolated in 2004, it has found applications in strengthening materials, accelerating electronics, and boosting performance in batteries, among others. It [...]
UK spots 33 cases of ANOTHER Covid variant
Another Covid variant that could dodge vaccine-triggered immunity has been identified in the UK, scientists say. The strain — called B.1.525 — has been spotted 33 times already but experts say this could be [...]
Spotlight on mRNA vaccines: Covid-19 approvals highlight a novel competitive landscape in oncology
The ongoing Covid-19 pandemic has yielded an unexpected advancement in the pharmaceutical industry with the approval of the first mRNA vaccines, which GlobalData expects will soon impact other indications. This historical landmark could have [...]
New AI Tool Can Thwart Coronavirus Mutations
USC researchers have developed a new method to counter emergent mutations of the coronavirus and hasten vaccine development to stop the pathogen responsible for killing thousands of people and ruining the economy. Using artificial [...]
Pfizer vaccine: Single dose ‘90 per cent effective after 21 days’
A single dose of the Pfizer coronavirus vaccine is “highly protective” after three weeks, according to a study. Researchers at the University of East Anglia (UEA) said the coronavirus vaccine developed by Pfizer and BioNTech was still effective [...]
COVID-19 Attack On Brain, Not Lungs, Triggers Severe Disease In Mice
Summary: Mice exposed to COVID-19 through the nasal passage, researchers noted a rapid and escalated attack on the brain by the virus that triggered a more severe outcome of the infection, even after the lungs [...]
GSK and CureVac sign £132m deal to develop multi-variant Covid vaccine
GlaxoSmithKline and Germany’s CureVac have reached a €150m (£132m) agreement to develop a next generation of Covid-19 vaccines targeting new emerging variants in the pandemic. The two companies said they plan to work jointly to [...]
Monoclonal antibodies: ‘great hope’ in Covid treatments fails against variants
The great hope for drug treatments against Covid-19 – the monoclonal antibodies – are failing against variants of the virus, such as those that have emerged in South Africa and Brazil, scientists have found. [...]
Nano ‘Smart bandage’ detects, could prevent infections
Bandages are great for covering wounds, but they would be much more useful if they could also detect infections. By embedding nanosensors in the fibers of a bandage, University of Rhode Island Assistant Professor [...]
Can We Stop a Super Coronavirus?
The new variants of the coronavirus are even more dangerous than those known so far. Researchers and politicians fear a sharp increase in the number of infections, with dramatic consequences like those seen in Britain. [...]